Sep 21, 2026 7 0
Uploaded by Rowan
Favorite
Share
More Options
16
NAPRT Silencing in FH-Deficient Renal Cell Carcinoma Confers Therapeutic Vulnerabilities via NAD+ Depletion_Page 1

Open in WPS to view all 16 pages